Antispasticity Medications - 06/07/18
Doi : 10.1016/S1047-9651(18)30200-6
Patricia W. Nance, MD a, ⁎, Robert R. Young, MD b
a From the Section of Rehabilitation Medicine, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
b The Department of Neurology, University of Southern California, Los Angeles, California
*Address reprint requests to Patricia W. Nance, MD, FRCPC, Section of Rehabilitation Medicine, Health Sciences Centre, RR265–800 Sherbrook Street, Winnipeg, MB R3A 1M4 CanadaSection of Rehabilitation MedicineHealth Sciences CentreRR265–800 Sherbrook StreetWinnipegMBR3A 1M4Canada
Résumé |
The article illustrates a practical approach to the challenging management of problematic, generalized spasticity. Use of dose titration to achieve symptomatic relief is described. Currently approved pharmaceuticals used as antispasticity agents and muscle relaxants and other medications with antispasticity effects are reviewed.
Le texte complet de cet article est disponible en PDF.© 1999
Elsevier Inc. Tous droits réservés.
Vol 10 - N° 2
P. 337-355 - mai 1999 Retour au numéro
Article précédent
- Antihypertensives
- Valsa Daniels, Alan Casey
- Neuromuscular Blockers
- Jean-Michel Gracies, David Simpson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?